Exane Derivatives’s Welltower WELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-27
Closed -$2.6K 1008
2022
Q1
$2.6K Buy
+27
New +$2.35K ﹤0.01% 734
2021
Q4
Sell
-7,127
Closed -$587K 1056
2021
Q3
$587K Sell
7,127
-5,659
-44% -$486K 0.14% 154
2021
Q2
$1.11M Sell
12,786
-2,519
-16% -$193K 0.25% 86
2021
Q1
$1.1M Sell
15,305
-1,693
-10% -$114K 0.31% 73
2020
Q4
$1.1M Buy
16,998
+4,124
+32% +$250K 0.32% 73
2020
Q3
$709K Sell
12,874
-1,043
-7% -$57.3K 0.21% 106
2020
Q2
$720K Buy
13,917
+1,073
+8% +$52.7K 0.19% 104
2020
Q1
$588K Sell
12,844
-7,444
-37% -$549K 0.16% 110
2019
Q4
$1.72M Buy
20,288
+4,022
+25% +$344K 0.32% 88
2019
Q3
$1.47M Hold
16,266
0.26% 84
2019
Q2
$1.33M Buy
16,266
+1,456
+10% +$114K 0.23% 89
2019
Q1
$1.15M Buy
14,810
+2,495
+20% +$187K 0.23% 99
2018
Q4
$855K Sell
12,315
-700
-5% -$47.6K 0.15% 133
2018
Q3
$826K Hold
13,015
0.15% 126
2018
Q2
$814K Hold
13,015
0.14% 137
2018
Q1
$718K Buy
+13,015
New +$735K 0.14% 145
2017
Q4
Sell
-3,734
Closed -$262K 642
2017
Q3
$262K Buy
3,734
+1,062
+40% +$77.2K 0.05% 186
2017
Q2
$200K Sell
2,672
-4,349
-62% -$318K 0.04% 202
2017
Q1
$497K Sell
7,021
-5,985
-46% -$404K 0.11% 131
2016
Q4
$870K Buy
13,006
+1,620
+14% +$107K 0.17% 97
2016
Q3
$851K Buy
11,386
+1,708
+18% +$131K 0.13% 102
2016
Q2
$737K Sell
9,678
-5,103
-35% -$362K 0.12% 103
2016
Q1
$1.02M Sell
14,781
-1,243
-8% -$80.1K 0.14% 87
2015
Q4
$1.09M Buy
+16,024
New +$1.05M 0.15% 80
2015
Q3
Sell
-16,982
Closed -$1.11M 574
2015
Q2
$1.11M Buy
16,982
+4,203
+33% +$301K 0.12% 84
2015
Q1
$989K Buy
12,779
+8,881
+228% +$699K 0.11% 97
2014
Q4
$295K Buy
+3,898
New +$278K 0.04% 181

Other funds holding WELL

Exane Derivatives's WELL Position: Q2 2022 in Review

Exane Derivatives sold out of Welltower (WELL) in Q2 2022, closing a stake of 27 shares — an estimated $2.6K sold.

Exane Derivatives first reported a position in WELL in Q4 2014 and held it in 27 quarters. The position peaked at $1.72M in Q4 2019. 818 funds tracked by Wall St. Rank hold WELL as of Q2 2022.

  • Exane Derivatives reported no remaining Welltower position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 27 Welltower shares in Q2 2022, an estimated $2.6K.
  • Exane Derivatives first reported a position in Welltower in Q4 2014 and held it in 27 quarters.
  • Exane Derivatives's Welltower position peaked at $1.72M in Q4 2019.
  • 818 funds tracked by Wall St. Rank held Welltower as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.